Fubini Ross 4
4 · Ginkgo Bioworks Holdings, Inc. · Filed Jun 14, 2024
Insider Transaction Report
Form 4
Fubini Ross
Director
Transactions
- Award
Stock Option
2024-06-13+1,111,111→ 1,111,111 totalExercise: $0.46Exp: 2034-06-13→ Class A Common Stock (1,111,111 underlying) - Award
Stock Option
2024-06-13+571,428→ 571,428 totalExercise: $0.46Exp: 2034-06-13→ Class A Common Stock (571,428 underlying) - Award
Restricted Stock Units
2024-06-13+432,900→ 432,900 totalExercise: $0.00→ Class A Common Stock (432,900 underlying)
Footnotes (5)
- [F1]In accordance with the Non-Employee Director Compensation Program of the Issuer, the Black-Scholes value of the initial option award as of the grant date is $400,000.
- [F2]The initial stock options shall vest and become exercisable in substantially equal installments on each of the first three anniversaries of the date of grant, such that the initial stock options shall be fully vested on the third anniversary of the date of grant, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.
- [F3]In accordance with the Non-Employee Director Compensation Program of the Issuer, the Black-Scholes value of the additional initial option award as of the grant date is $200,000.
- [F4]The vesting date of the RSUs and additional initial options, and in the case of the additional initial options, the exercise date, will be the day immediately prior to the date of the next Annual Meeting of Shareholders of the Issuer occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.
- [F5]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.